Part of the Menarini Group, Lusochimica aims to create a greener, more efficient synthesis of nebivolol, a widely used cardiovascular drug. The project will immobilise two alcohol dehydrogenase enzymes on solid support and integrate them into flow chemistry, optimising conditions at the laboratory and pilot scale. By establishing a European-based, competitive production, this initiative enhances sustainability, scalability, and pharmaceutical sovereignty.
- Beneficiaries
Coordinators: Lusochimica
- Project Locations
Italy
- EU funding
€ 1 733 593.00
- Funding sources
Other STEP stories
OpenEuroLLM will develop a family of Large Language Model (LLMs) covering all EU official languages, ensuring transparency, compliance with the AI Act, and uptake among European businesses, startups, and innovators
PUMA will further develop Europe’s radiation-hardened integrated circuits, establishing a European capability in cutting-edge and high reliability space equipment
SPACELINK will establish Europe’s first independent supply chain for space-grade optical transceivers.